The Centre for Medicines Research (CMR) International, a wholly owned subsidiary of Clarivate Analytics, pioneered the development of reliable approaches to benchmarking pharmaceutical R&D.
In an industry where success depends on objective, actionable data analysis, our programs are the most reliable source that a majority of the world’s leading companies rely on for performance evaluation.
Our programs are ongoing and focused on key issues, with datasets built over 20 years of rigorous development. The datasets apply unique depth and historical context to uncover reliable industry trends, set against the changing marketplace. Participate in one of our flagship benchmarking programs to support your R&D success: Global R&D Performance Metrics Program, Global Clinical Performance Program, and Asia Pacific Performance Program.
The Global R&D Performance Metrics Program provides independent, reliable, and contemporary R&D benchmarks that you can easily apply with confidence. It includes a suite of company-specific outputs, including benchmarking reports and online analytical tools. In addition, you can participate in several of the industry roundtable meetings we hold each year, which provide a forum to discuss R&D trends with peers in an open and confidential manner.
The Global Clinical Performance Metrics Program provides independent, reliable and up-to-date clinical benchmarks that track clinical activity trends. As a member, you’ll receive a suite of company-specific outputs including benchmarking reports and online analytical tools. In addition, you can participate in several of the industry roundtable meetings we organize each year, which provide a benchmarking forum to discuss R&D development trends with peers in an open and confidential manner.
Become a member of the Asia Pacific Performance Metrics Program to get independent, reliable and up-to-date R&D and clinical benchmarks that track clinical activity trends in Japan, China, India, South Korea and Taiwan. These benchmarks include pipeline progression in the region, success rates, trial density, patient numbers, cycle times and regulatory strategy. You’ll receive company-specific outputs including benchmarking reports and online analytical tools. In addition, you can participate in several of the industry roundtable meetings we organize each year, which provide a forum to discuss R&D development trends with peers in an open and confidential manner.
Benefit from a proven and secure process that collects, validates and analyzes industry-wide, proprietary R&D performance metrics.
Guarantee the value and integrity of performance data through meticulous audit procedures.
Get the vital, actionable analytics data you need by partnering with us for a customized approach.
Gain an in-depth understanding of the latest industry dynamics and trends with the CMR International Pharmaceutical R&D Factbook, the definitive business planning report.
Drill down to robust underlying data and analyze trends using more than 70 fully interactive charts, tables and graphs – all easily exportable to your presentations and reports.
Give your people unlimited access to the rich-data enterprise output – install on your company network or intranet, or distribute openly to any employee.
Years of global pharma R&D performance analysis
Of top 20 pharma work with CMR
Our accredited global alliance program delivers value-added solutions by combining offerings from Clarivate with other technology and service providers. Partner with us to drive profitable growth, increase revenue and deliver greater value to your customers.